Table of contents
- Original news
- What is the background to this case?
- What were the main points in this case?
- How did the court approach obviousness?
- How did the court decide on insufficiency?
- Which kind of insufficiency?
- What about the plausibility test?
- What is the significance of events that happen after the patent filing date?
- Are Phase II or Phase III trials most important when considering efficacy?
- Does this case provide any principles of general application?
More sections of this document available when you sign-in to Lexis+ or register for a free trial.
Article summary
IP & IT analysis: Are sufficiency tests harder for pharma patents (particularly vaccines and other medicines) than for other patents?
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial